
PerkinElmer PKI
Quartalsbericht 2026-Q1
hinzugefügt 12.05.2026
PerkinElmer Kurzfristige Verbindlichkeiten 2011-2026 | PKI
Kurzfristige Verbindlichkeiten Jährlich PerkinElmer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.33 B | 653 M | 1.45 B | 1.21 B | 1.65 B | - | 763 M | 772 M | 951 M | 561 M | - | 597 M | 603 M | 581 M | 515 M | 497 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.65 B | 497 M | 867 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
1.71 B | $ 114.7 | 0.85 % | $ 34.9 B | ||
|
Celcuity
CELC
|
44.2 M | $ 142.1 | 1.26 % | $ 6.64 B | ||
|
Co-Diagnostics
CODX
|
3.54 M | $ 3.81 | 59.41 % | $ 5.07 M | ||
|
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
68.7 M | $ 20.36 | 1.65 % | $ 590 M | ||
|
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | ||
|
Fulgent Genetics
FLGT
|
72.9 M | $ 17.25 | 5.12 % | $ 522 M | ||
|
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
303 M | $ 117.53 | 2.22 % | $ 14.7 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
89.8 M | $ 21.58 | 2.03 % | $ 1.15 B | ||
|
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
4.05 M | - | - | $ 9.42 M | ||
|
ICON Public Limited Company
ICLR
|
2.8 B | $ 116.36 | 1.1 % | $ 9.6 B | ||
|
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
1.55 B | $ 146.35 | 3.12 % | $ 23.3 B | ||
|
Interpace Biosciences
IDXG
|
5.1 M | $ 1.8 | - | $ 7.96 M | ||
|
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | ||
|
Lantheus Holdings
LNTH
|
333 M | $ 94.54 | -1.61 % | $ 6.38 B | ||
|
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
1.12 B | $ 160.56 | 2.86 % | $ 7.96 B | ||
|
Medpace Holdings
MEDP
|
1.34 B | $ 428.63 | 1.6 % | $ 12.4 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | ||
|
Mettler-Toledo International
MTD
|
1.2 B | $ 1 093.83 | 0.99 % | $ 22.5 B | ||
|
NeoGenomics
NEO
|
88.3 M | $ 9.01 | 1.18 % | $ 1.15 B | ||
|
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
36.6 M | $ 19.15 | -0.58 % | $ 429 M | ||
|
Natera
NTRA
|
310 M | $ 202.54 | -1.16 % | $ 19.9 B | ||
|
Myriad Genetics
MYGN
|
134 M | $ 3.8 | -0.26 % | $ 352 M | ||
|
Personalis
PSNL
|
39.6 M | $ 8.33 | 4.78 % | $ 743 M | ||
|
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | ||
|
Senseonics Holdings
SENS
|
24.3 M | $ 6.04 | 5.78 % | $ 252 M | ||
|
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
61.4 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
1.74 M | $ 2.41 | 2.55 % | $ 5.54 M | ||
|
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 255.67 | -0.68 % | $ 21.3 B | ||
|
Thermo Fisher Scientific
TMO
|
15.2 B | $ 451.27 | -0.08 % | $ 170 B | ||
|
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
91.4 M | $ 57.74 | 7.6 % | $ 3.45 B | ||
|
Neogen Corporation
NEOG
|
174 M | $ 8.84 | 0.11 % | $ 1.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 193.55 | -0.09 % | $ 21.5 B | ||
|
Waters Corporation
WAT
|
1.24 B | $ 341.66 | 0.12 % | $ 20.3 B |